An additive effect on levels of intact GLP-1 has also been reported in patients with T2DM receiving metformin and vildagliptin concomitantly as compared with drug-naïve patients receiving only vildagliptin [13], which further supports the use of this combination of drugs [41,42]. Here, GCG is linked to type 2 diabetes mellitus.